Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Esophageal Squamous Cell Carcinoma 1Digestive System Neoplasms 1

Interventions

Oxaliplatin 3Magnetic Resonance Spectroscopy 3Exercise Test 2Cyclophosphamide 2Capecitabine 2trifluridine tipiracil drug combination 1penpulimab 1pembrolizumab 1lutetium Lu 177 dotatate 1huachansu 1guadecitabine 1copper dotatate CU-64 1XELOX 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Restraint, Physical 1Physical Examination 1Oviposition 1Observation 1Lutetium-177 1Lutetium 1Irinotecan 1Indocyanine Green 1Hyperthermic Intraperitoneal Chemotherapy 1Health Information Exchange 1Gemcitabine 1Gastroscopy 1Fluorouracil 1Fluorescein 1Endoscopy, Digestive System 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Diseases × huachansu × Clear all
NCT00837239 2012-07-12

Huachansu & Gemcitabine in Pancreatic Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled
Gastrointestinal

Gastrointestinal Diseases, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡